Monoclonal Antibody Pemgarda Authorized as COVID Protection for At-Risk Groups
People who have difficulty building immunity from COVID-19 vaccines now have a new medication to turn to for help.The U.S. Food and Drug Administration (FDA) issued an emergency use authorization for Pemgarda, a preventative medication designed for immunocompromised individuals. The EUA was granted …
Read More